Similarly, for patients positive for both AFP and DCP preoperatively, the prognosis progressively improves as the number of positive tumor markers turning negative postoperatively increases (Figure 3), particularly for those reaching double negative postoperatively, whose prognosis is akin to preoperatively double-negative patients. This evidence concerns the gene AFP and neoplasm.